Riemser Arzneimittel AG Overview

Life ScienceCompany

Was Riemser Arzneimittel AG formerly PE-backed?

Yes. Riemser Arzneimittel AG was formerly owned by 2 private investors.

Where is Riemser Arzneimittel AG headquartered?

Riemser Arzneimittel AG is headquartered in Greifswald - Insel Riems, Germany.

What sector is Riemser Arzneimittel AG in?

Riemser Arzneimittel AG is a life science company.

When was Riemser Arzneimittel AG founded?

Riemser Arzneimittel AG was founded in 1992.

Riemser Arzneimittel AG

An der Wiek 7,
Greifswald - Insel Riems, 17493
Germany,
+49 30 338427-0
www.riemser.de

Riemser Arzneimittel AG is a pharmaceutical company focuses on its activities is mainly due to the distribution and life cycle management of pharmaceuticals in therapeutic niche areas with high unmet medical needs. Riemser product range especially covers prescription drugs to treat serious diseases in the therapeutic areas of oncology, infectiology, neurology, in the cardiovascular field, in dermatology, rheumatology, tuberculosis treatment, for the treatment of obesity and primary axillary hyperhidrosis.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 2 - - - - - 2
Sell (0.0/yr) # - - - - - - 0
  2

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Riemser Arzneimittel AG

Life Science Companies , Germany Companies